Teladoc Health Inc. (TDOC) stock surged 14.73% during Thursday's trading session, outperforming the broader market.
The telehealth company's shares rallied amid bullish options trading activity, with call option volume significantly higher than normal levels. Additionally, positive analyst commentary from Citron Research boosted investor sentiment towards Teladoc's growth prospects.
According to Citron Research, the market is "sleeping" on Teladoc, and the firm sees the stock rerating higher. The positive outlook stems from Teladoc's recent acquisition of Catapult Health, which is expected to leverage technology to cut costs, improve care, and expand margins.